INTERACTION BETWEEN CHICKEN ANEMIA VIRUS AND LIVE NEWCASTLE-DISEASE VACCINE

Citation
Gf. Deboer et al., INTERACTION BETWEEN CHICKEN ANEMIA VIRUS AND LIVE NEWCASTLE-DISEASE VACCINE, Avian pathology, 23(2), 1994, pp. 263-275
Citations number
32
Categorie Soggetti
Veterinary Sciences
Journal title
ISSN journal
03079457
Volume
23
Issue
2
Year of publication
1994
Pages
263 - 275
Database
ISI
SICI code
0307-9457(1994)23:2<263:IBCAVA>2.0.ZU;2-4
Abstract
Three groups of 150 SPF chickens were spray-vaccinated with live Newca stle disease La Sota-type vaccine (clone 30) at one day of age, and an other three groups were NDV spray-vaccinated at 10 days of age. In eac h of the two series of NDV-vaccinated groups, one group also received at day-old 10(5) TCID50 of chicken anaemia virus (CAV) also and anothe r group 10(5) TCID50 of CAV plus a low dose of virulent Marek's diseas e virus (MDV). After one week, chickens of the groups which had been N DV-vaccinated and CAV-infected at day-old, with or without MDV, showed severe respiratory distress, conjunctivitis, drooping wings and ruffl ed feathers. After two weeks, wet and inflamed eyes were observed. Aft er three weeks the respiratory problems were overcome, but the entire group showed retarded growth as compared with the group which had rece ived NDV vaccine only. The 'respiratory sounds' were milder in the chi ckens NDV-vaccinated at 10 days of age, about 10% of the chickens show ing retarded growth. Mortality in CAV-infected chickens which had rece ived NDV vaccine at day-old was above 30% at 4 weeks of age, and betwe en 15 and 20% when NDV had been administered at the age of 10 days, an d was 5% in the two NDC vaccine control groups. Decreased haematocrit levels were measured in all four CAV-infected groups at 14 days of age . In serum samples collected for 6 weeks at weekly intervals from chic kens of the six groups, no differences were observed between HI antibo dy titres against NDV virus. Thus, dual infection with CAV and live ND V vaccine did not impair the humoral immune response against attenuate d Newcastle disease vaccine.